Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer—central evaluation of FIRE-3

Autor: Modest, D.P., Denecke, T., Pratschke, J., Ricard, I., Lang, H., Bemelmans, M., Becker, T., Rentsch, M., Seehofer, D., Bruns, C.J., Gebauer, B., Modest, H.I., Held, S., Folprecht, G., Heinemann, V., Neumann, U.P.
Zdroj: In European Journal of Cancer January 2018 88:77-86
Databáze: ScienceDirect